Display Settings:

Format

Send to:

Choose Destination
    Breast Cancer Res. 2003;5(1):23-6. Epub 2002 Oct 11.

    Expression profiling to predict outcome in breast cancer: the influence of sample selection.

    Source

    Department of Oncology, The Jubileum Institute, Lund University Hospital, Lund, Sweden.

    Abstract

    Gene expression profiling of tumors using DNA microarrays is a promising method for predicting prognosis and treatment response in cancer patients. It was recently reported that expression profiles of sporadic breast cancers could be used to predict disease recurrence better than currently available clinical and histopathological prognostic factors. Having observed an overlap in those data between the genes that predict outcome and those that predict estrogen receptor-alpha status, we examined their predictive power in an independent data set. We conclude that it may be important to define prognostic expression profiles separately for estrogen receptor-alpha-positive and estrogen receptor-alpha-negative tumors.

    PMID:
    12559041
    [PubMed - indexed for MEDLINE]
    PMCID: PMC154130
    Free PMC Article

    Images from this publication.See all images (4) Free text

    Figure 1
    Figure 3
    Figure 4
    Figure 2

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk